However, in breast cancer, this regulation is subtype-specific: while Subcapsular sinus macrophages (72)and CD169+ TAMs (75) suppress B cell activation, CD169+ monocyte-derived macrophages (75) promote B cell activation, highlighting the functional diversity of macrophages in TME. Here, SIGLEC1 is linked to breast carcinoma.